GENEVA:The World Health Organization chief on Monday lambasted drugmakers' profits and vaccine inequalities, saying it’s “not right” that younger, healthier adults in wealthy countries get vaccinated against COVID-19 before older people or health care workers in poorer countries and charging that most vaccine makers have targeted locations where “profits are highest.”
Director-General Tedros Adhanom Ghebreyesus kicked off the WHO’s week-long executive board meeting — virtually from its headquarters in Geneva — by lamenting that one poor country received a mere 25 vaccine doses while over 39 million doses have been administered in nearly 50 richer nations.
“Just 25 doses have been given in one lowest income country -- not 25 million, not 25,000 -- just 25. I need to be blunt: The world is on the brink of a catastrophic moral failure,” Tedros said. He did not specify the country, but a WHO spokeswoman identified it as Guinea.
“It’s right that all governments want to prioritize vaccinating their own health workers and older people first," he said. “But it’s not right that younger, healthier adults in rich countries are vaccinated before health workers and older people in poorer countries. There will be enough vaccine for everyone.”
Tedros, an Ethiopian who goes by his first name, nonetheless hailed the scientific achievement behind rolling out coronavirus vaccines less than a year after the pandemic erupted in China, where a WHO-backed team has now been deployed to look into origins of the coronavirus.
“Vaccines are the shot in the arm we all need, literally and figuratively,” Tedros said. “But we now face the real danger that even as vaccines bring hope to some, they become another brick in the wall of inequality between the worlds of the world’s haves and have-nots.”
He noted the WHO-backed COVAX program, which aims to get vaccines out to all countries, rich or poor, based on need, has so far secured 2 billion vaccine doses from five producers and options on a billion doses more.
“We aim to start deliveries in February,” he said. "COVAX is ready to deliver what it was created for.”
That target date could be a tall order, because a key producer of vaccines for the developing world — the Serum Institute of India — has not confirmed a date and predicted that its rollout might not happen before March or April.
In his opening remarks, Tedros aired some of his toughest public words yet toward vaccine makers, criticizing “bilateral deals” between them and countries that the WHO says can deplete the effectiveness of the COVAX facility — and went further to raise the issue of profits.
“The situation is compounded by the fact that most manufacturers have prioritized regulatory approval in rich countries, where the profits are highest, rather than submitting full dossiers to WHO,” he said.
That appeared to allude to a shortage of data the U.N. health agency says it has received from vaccine makers so that the WHO can approve their shots for wider emergency use.
Dr. Clement Martin Auer, a board member from Austria, had sharp words and questions for GAVI, the Vaccine Alliance, that also with the Coalition for Epidemic Preparedness Innovations is leading the effort on COVAX.
While calling its principles of equal access to vaccines a “fantastic idea,” Auer faulted COVAX as being “slow” and unable to close “crucial numbers" of contracts. He defended the European Union, which counts among its 27 members many of the world's richest countries, for getting vaccines for its 450 million citizens and being “the single largest donor” in supporting COVAX.
“We were, in the European Union, skeptical that GAVI-COVAX had the means and the capabilities to fulfill its tasks and negotiate the necessary contracts and to secure the needs of our citizens,” Auer said, adding that COVAX management had “rejected” proposals negotiated by GAVI and the EU.
He said GAVI-COVAX early last year had not included mRNA vaccines like those developed by Pfizer-BioNTech and Moderna in the COVAX portfolio.
“This was a major mistake, taking into account that the mRNAs are the early ones on the market and the gold standards when it comes to COVID vaccines,” Auer said.
The WHO has approved Pfzier-BioNTech for emergency use against coronavirus and could approve Moderna this week.
Dr. Bruce Aylward, a special adviser to Tedros, said that the WHO was in “detailed discussions with Pfizer. We believe very soon we will have access to that product.” He said the mRNA vaccines are “important” but are “extremely difficult” — alluding to cold-chain requirements, among other things, and are “extremely expensive."
“What we are gunning for is to get 20% of the world, at least, vaccinated this year, and more ideally,” Aylward said. "We are in a strong position to move out with vaccines globally. We just need the assistance of our member states in particular to make sure that becomes the reality.”
In related vaccine news, Israel has struck a deal with Pfizer, promising to share vast troves of medical data with the international drug giant in exchange for the continued flow of its hard-to-get vaccine.
Proponents say the deal could allow Israel to become the first country to vaccinate most of its population, while providing valuable research that could help the rest of the world. But critics say the deal raises major ethical concerns, including possible privacy violations and a deepening of the global divide in access to coronavirus vaccines.
Due to the ultra-cold storage needed for the Pfizer vaccine, it is more expensive and harder to use than some rivals, including the Oxford-AstraZeneca vaccine, but studies show it is very effective. Israeli media have reported that Israel paid at least 50% more than other countries for the Pfizer vaccine.
AP Newsroom
Tue Jan 19 2021
A member of staff at the university hospital injects the Moderna vaccine against COVID-19 into a patient in Duesseldorf, Monday, Jan. 18, 2021. (Federico Gambarini/dpa via AP)
Who is Prabowo Subianto, incoming president of Indonesia?
A wealthy ex-general with ties to Indonesia's popular outgoing president and its dictatorial past, looks set to be its next leader.
Iran's supreme leader says Hamas leader's death will not halt 'Axis of Resistance'
The "Axis of Resistance", built up with years of Iranian support, includes Hamas, the Lebanese Hezbollah group, the Houthi movement in Yemen, and various Shi'ite groups in Iraq and Syria.
Putin says Russia willing to seek compromises between Iran and Israel
Russia is ready to help seek compromises between arch-foes Israel and Iran, President Vladimir Putin said on Friday, saying these would be difficult but possible.
What proposals will Russia push at the BRICS summit?
The proposal is also to establish a BRICS reinsurance company to allow uninterrupted shipment of goods and key commodities between members.
Indonesia's free meals plan in the spotlight as Prabowo readies for office
Prabowo calls the programme one of the main drivers of economic growth, eventually set to add an estimated 2.5 million jobs.
Astro AWANI's revamped English news website, AWANI International, launches on Oct 21
Astro AWANI's revamped English platform delivers in-depth global news and expert analysis to keep you informed on key developments.
Israeli strikes kill 33 people in Jabalia refugee camp in Gaza, medics say
Residents of Jabalia said Israeli tanks had reached the heart of the camp after pushing through suburbs and residential districts.
Liam Payne's ex-partner calls for media restraint after 'painful' death
Cheryl Tweedy used her statement to urge the media to remember they had a seven-year-old son, Bear, who could read the reports.
Analysts: Indonesia's strong MoF leadership team to boost investor confidence
Sri Mulyani Indrawati as head of Indonesia's Ministry of Finance is expected to instil confidence among investors.
Biden offers both a carrot and a stick to Israel as his term nears an end
Israel has frequently resisted US advice and has caused political difficulties for the Biden administration.
Putin says BRICS will generate most of global economic growth
Russian President Vladimir Putin will host a summit of the group in the city of Kazan on Oct. 22-24.
ISIS Malaysia's perspective of Budget 2025
An excellent rakyat-centric budget under the overarching principle of a caring and humane economy.
Budget 2025: Record increase in STR, SARA aid initiatives
The government will provide a significant boost to the Sumbangan Tunai Rahmah (STR) and Sumbangan Asas Rahmah (SARA) initiatives next year.
Budget 2025: EPF contributions to be made mandatory for foreign workers – PM Anwar
The government plans to make it compulsory for all non-citizen workers to contribute to the Employees Provident Fund (EPF).
What policies to expect from Indonesia's new President Prabowo
Prabowo will be open to foreign investment, his aide has said, such as by offering investors management of airports and sea ports.
Budget 2025: Govt allocates RM470 mil to empower women's participation in PMKS
The Women's Leadership Apprenticeship Program will be intensified as an effort to produce more female corporate personalities.
Israel sends more troops into north Gaza, deepens raid
Residents of Jabalia in northern Gaza said Israeli tanks had reached the heart of the camp, using heavy air and ground fire.
Indonesia ramps up security ahead of Prabowo's inauguration
Prabowo Subianto will be sworn in as Indonesia's president on Sunday with Vice President-elect, Gibran Rakabuming Raka, also taking office.
Immediate allocation of RM150 mil for local authorities, DID to tackle flash floods
Datuk Seri Anwar Ibrahim said this allocation is intended to address the recent flash floods that hit the capital and several major towns.
Budget 2025: Sabah, Sarawak to continue receiving among highest allocations - PM
Sabah and Sarawak continues to be prioritised under Budget 2025, with allocations of RM6.7 billion and RM5.9 billion respectively.